FabAV antivenin use after copperhead snakebite: clinically indicated or knee-jerk reaction?

Gale, Stephen C; Peters, Jo Ann; Allen, LaDonna; Creath, Robert; Dombrovskiy, Viktor Y.
J. Venom. Anim. Toxins incl. Trop. Dis. ; 22: [1-6], Fevereiro 19, 2016. tab
Artigo em Inglês | VETINDEX | ID: vti-15608

Documentos relacionados

  1. FabAV antivenin use after copperhead snakebite: clinically indicated or knee-jerk reaction?
  2. A strategy for the enrichment and characterization of disulfide bond-contained proteins from Chinese cobra (Naja atra) venom.
  3. Experience of using expired lyophilized snake antivenom during a medical emergency situation in Lao People's Democratic Republic--A possible untapped resource to tackle antivenom shortage in Southeast Asia.
  4. Advanced approaches for endotoxin detection and removal from snake antivenoms.
  5. Venomous animals in a changing world.
  6. Protein decomplexation and proteomics: A complementary assessment method of the physicochemical purity of antivenom.
  7. Recombinant snake antivenoms get closer to the clinic.
  8. Prospective study of recovery from copperhead snake envenomation: an observational study.
  9. Evaluation of the stability of Yamakagashi (Rhabdophis tigrinus) Equine Antivenom after 20 years storage.
  10. Benefits of Sebastiania hispida (Euphorbiaceae) extract and photobiomodulation therapy as potentially adjunctive strategies to be explored against snake envenoming.